SHIBANI SHAH: Open Payments
NPI 1326719063 · NEWPORT BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,603 in 62 payments from 16 companies in 2025. Trend: 2023 $4,626 · 2024 $3,257 · 2025 $2,603
Food & beverage: $2,448Education: $155
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 16 | $710 |
| UCB, Inc. | 7 | $516 |
| Novartis Pharmaceuticals Corporation | 8 | $223 |
| Incyte Corporation | 4 | $192 |
| GENZYME CORPORATION | 4 | $176 |
| Janssen Biotech, Inc. | 6 | $163 |
| LEO Pharma Inc. | 4 | $114 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $102 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Almirall LLC | 1 | $86 |
Products named: Zoryve, Bimzelx, DUPIXENT, COSENTYX, OPZELURA, TREMFYA, ADBRY, SPEVIGO.
Industry payments across CA — which companies pay providers there.
